Daniel A Barocas1, David F Penson. 1. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. dan.barocas@vanderbilt.edu
Abstract
OBJECTIVE: To review the literature on racial variation in the pattern of care (PoC) and quality of care (QoC) for prostate cancer, as there are known racial disparities in the incidence and outcomes of prostate cancer. While there are some biological explanations for these differences, they do not completely explain the variation. Differences in the appropriateness and QoC delivered to men of different racial groups may contribute to disparities in outcome. METHODS: We searched the USA National Library of Medicine PubMed system for articles pertaining to quality indicators in prostate cancer and racial disparities in QoC for prostate cancer. RESULTS: While standards for appropriate treatment are not clearly defined, racial variation in the PoC has been reported in several studies, suggesting that African-American men may receive less aggressive treatment. There are validated QoC indicators in prostate cancer, and researchers have begun to evaluate racial variation in adherence to these quality indicators. Further quality comparisons, particularly in structural measures, may need to be performed to fully evaluate differences in QoC. CONCLUSIONS: There is mounting evidence for racial variation in the PoC and QoC for prostate cancer, which may contribute to observed differences in outcome. While some of the sources of racial variation in quality and outcome have been identified through the development of evidence-based guidelines and validated quality indicators, opportunities exist to identify, study and attempt to resolve other components of the quality gap.
OBJECTIVE: To review the literature on racial variation in the pattern of care (PoC) and quality of care (QoC) for prostate cancer, as there are known racial disparities in the incidence and outcomes of prostate cancer. While there are some biological explanations for these differences, they do not completely explain the variation. Differences in the appropriateness and QoC delivered to men of different racial groups may contribute to disparities in outcome. METHODS: We searched the USA National Library of Medicine PubMed system for articles pertaining to quality indicators in prostate cancer and racial disparities in QoC for prostate cancer. RESULTS: While standards for appropriate treatment are not clearly defined, racial variation in the PoC has been reported in several studies, suggesting that African-American men may receive less aggressive treatment. There are validated QoC indicators in prostate cancer, and researchers have begun to evaluate racial variation in adherence to these quality indicators. Further quality comparisons, particularly in structural measures, may need to be performed to fully evaluate differences in QoC. CONCLUSIONS: There is mounting evidence for racial variation in the PoC and QoC for prostate cancer, which may contribute to observed differences in outcome. While some of the sources of racial variation in quality and outcome have been identified through the development of evidence-based guidelines and validated quality indicators, opportunities exist to identify, study and attempt to resolve other components of the quality gap.
Authors: James A Eastham; Michael W Kattan; Elyn Riedel; Colin B Begg; Thomas M Wheeler; Claudia Gerigk; Mithat Gonen; Victor Reuter; Peter T Scardino Journal: J Urol Date: 2003-12 Impact factor: 7.450
Authors: Christopher L Amling; Robert H Riffenburgh; Leon Sun; Judd W Moul; Raymond S Lance; Leo Kusuda; Wade J Sexton; Douglas W Soderdahl; Timothy F Donahue; John P Foley; Andrew K Chung; David G McLeod Journal: J Clin Oncol Date: 2003-12-22 Impact factor: 44.544
Authors: Paul A Godley; Anna P Schenck; M Ahinee Amamoo; Victor J Schoenbach; Sharon Peacock; Michelle Manning; Michael Symons; James A Talcott Journal: J Natl Cancer Inst Date: 2003-11-19 Impact factor: 13.506
Authors: John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas Journal: N Engl J Med Date: 2003-11-27 Impact factor: 91.245
Authors: Marlene Camacho-Rivera; Samuel L Rice; Sehyun Oh; Manuel Paris; Ezinne Akpara; Justen Molina; Michael Obadina; Shireene Mcmillan; Joshua L Mendez Aracena; Jason Morency; Rosario Costas Muniz; Francesca Gany; Carol L Brown; Jason Gonsky; Joseph R Osborne Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-02-07 Impact factor: 4.254
Authors: Moritz F Sinner; Melissa A Greiner; Xiaojuan Mi; Adrian F Hernandez; Paul N Jensen; Jonathan P Piccini; Soko Setoguchi; Allan J Walkey; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis Journal: Clin Cardiol Date: 2012-09-13 Impact factor: 2.882
Authors: Carolyn J Presley; Ann C Raldow; Laura D Cramer; Pamela R Soulos; Jessica B Long; James B Yu; Danil V Makarov; Cary P Gross Journal: J Geriatr Oncol Date: 2013-01 Impact factor: 3.599
Authors: Ryan D Ross; Xu Shi; Megan E V Caram; Pheobe A Tsao; Paul Lin; Amy Bohnert; Min Zhang; Bhramar Mukherjee Journal: Health Serv Outcomes Res Methodol Date: 2020-10-20
Authors: Daniel A Barocas; Vivien Chen; Matthew Cooperberg; Michael Goodman; John J Graff; Sheldon Greenfield; Ann Hamilton; Karen Hoffman; Sherrie Kaplan; Tatsuki Koyama; Alicia Morgans; Lisa E Paddock; Sharon Phillips; Matthew J Resnick; Antoinette Stroup; Xiao-Cheng Wu; David F Penson Journal: J Comp Eff Res Date: 2013-07 Impact factor: 1.744
Authors: Shellie D Ellis; Bonny Blackard; William R Carpenter; Merle Mishel; Ronald C Chen; Paul A Godley; James L Mohler; Jeannette T Bensen Journal: Cancer Date: 2013-04-10 Impact factor: 6.860
Authors: Robert T Dess; Holly E Hartman; Brandon A Mahal; Payal D Soni; William C Jackson; Matthew R Cooperberg; Christopher L Amling; William J Aronson; Christopher J Kane; Martha K Terris; Zachary S Zumsteg; Santino Butler; Joseph R Osborne; Todd M Morgan; Rohit Mehra; Simpa S Salami; Amar U Kishan; Chenyang Wang; Edward M Schaeffer; Mack Roach; Thomas M Pisansky; William U Shipley; Stephen J Freedland; Howard M Sandler; Susan Halabi; Felix Y Feng; James J Dignam; Paul L Nguyen; Matthew J Schipper; Daniel E Spratt Journal: JAMA Oncol Date: 2019-07-01 Impact factor: 31.777